Estimaciones de analistas de Wall Street para BriaCell Therapeutics Corp. (BCTX): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Ratios de valoración
| Precio / Valor contable | 1.06 |
| EV / EBITDA | -0.75 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $1803 | $290 | $16877 | $18833 | $18735 | $15580 | $15139 | $15529 | $82573 | $147888 |
| Beneficio Bruto | -$1803 | -$289 | -$16877 | -$18833 | -$18735 | -$15580 | -$15139 | -$15529 | -$82573 | -$147888 |
| I+D | $952150 | $2.1M | $3.1M | $4.9M | $3.0M | $2.5M | $10.3M | $20.5M | $27.2M | $29.5M |
| Generales y Administrativos | $1.2M | $1.1M | $1.8M | $1.3M | $1.8M | $6.2M | $9.3M | $10.6M | $6.2M | $8.1M |
| Gastos Operativos | $2.2M | $3.2M | $5.0M | $6.2M | $4.8M | $8.7M | $19.6M | $31.1M | $33.3M | $37.6M |
| Beneficio Operativo | -$2.2M | -$3.2M | -$5.0M | -$6.3M | -$5.3M | -$8.7M | -$19.6M | -$31.1M | -$33.3M | -$37.7M |
| EBITDA | -$2.2M | -$3.2M | -$5.4M | -$5.8M | -$4.8M | -$17.1M | -$34.4M | -$31.1M | -$4.8M | -$37.6M |
| Gastos por Intereses | 0 | 0 | $20344 | $31467 | $36204 | $100217 | $1244 | 0 | 0 | $51288 |
| Beneficio Antes de Impuestos | -$2.2M | -$3.2M | -$5.4M | -$5.8M | -$5.4M | -$17.3M | -$34.4M | -$27.1M | -$4.9M | -$36.8M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$2.2M | -$3.2M | -$5.4M | -$5.8M | -$4.9M | -$17.3M | -$34.4M | -$27.1M | -$4.8M | -$36.5M |
| BPA | $-1360.30 | $-1348.63 | $-1798.34 | $-1505.30 | $-5.64 | $-13.50 | $-257.58 | $-192.55 | $-43.01 | $-62.60 |
| BPA Diluido | $-1360.30 | $-1348.63 | $-1798.34 | $-1505.30 | $-5.64 | $-13.50 | $-259.50 | $-195.00 | $-43.01 | $-62.60 |
| Acciones en Circulación (Diluidas) | $19231 | $22647 | $28520 | $38644 | $47592 | $301305 | $1.0M | $1.0M | $1.1M | $1.9M |
Precio
| Precio | $3.56 |
| Capitalización | $31M |
| Bolsa | NASDAQ |
| País | CA |
Empresas relacionadas: ALLR · ASBP · CRIS · CTXR · ENTO · HOTH · LPTX
Explorar sector: Healthcare · Biotechnology
Más secciones de BCTX: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones